Stay updated with breaking news from Eric Jonasch. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Eric Jonasch, MD, discusses the goals of a meeting sponsored by the International Kidney Cancer Coalition that will focus on patient advocacy in GU malignancies.
An expert discusses three crucial conversations about cancer care that patients should have with their health care providers.
Eric Jonasch, MD, discusses the evolution of belzutifan in cancer care, highlighting the agent’s potential for the treatment of patients with renal cell carcinoma.
Researchers continue to investigate novel immunotherapy drugs for the treatment of renal cell carcinoma.
Further understanding of the cancer immunity cycle could drive the development of novel immune therapies for patients with renal cell carcinoma.